Droplet digital PCR : An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19465 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Shengqiao Mao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasm, Residual, Polymerase Chain Reaction, Hematopoietic Stem Cell Transplantation, Leukemia, Myelomonocytic, Juvenile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Juvenile myelomonocytic leukaemia (JMML) is a rare myeloproliferative neoplasm requiring haematopoietic stem cell transplantation (HSCT) for potential cure. Relapse poses a significant obstacle to JMML HSCT treatment, as the lack of effective minimal residual disease (MRD)‐monitoring methods leads to delayed interventions. This retrospective study utilized the droplet digital PCR (ddPCR) technique, a highly sensitive nucleic acid detection and quantification technique, to monitor MRD in 32 JMML patients. The results demonstrated that ddPCR detected relapse manifestations earlier than traditional methods and uncovered molecular insights into JMML MRD dynamics. The findings emphasized a critical 1‐ to 3‐month window post‐HSCT for detecting molecular relapse, with 66.7% (8/12) of relapses occurring within this period. Slow MRD clearance post‐HSCT was observed, as 65% (13/20) of non‐relapse patients took over 6 months to achieve ddPCR‐MRD negativity. Furthermore, bone marrow ddPCR‐MRD levels at 1‐month post‐HSCT proved to be prognostically significant. Relapsed patients exhibited significantly elevated ddPCR‐MRD levels at this time point ( p = 0.026), with a cut‐off of 0.465% effectively stratifying overall survival ( p = 0.007), event‐free survival ( p = 0.035) and cumulative incidence of relapse ( p = 0.035). In conclusion, this study underscored ddPCR's superiority in JMML MRD monitoring post‐HSCT. It provided valuable insights into JMML MRD dynamics, offering guidance for the effective management of JMML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Shengqiao Mao, Xia Qin, Jing Chen
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Mao, S., Lin, Y., Qin, X., Miao, Y., Luo, C., Luo, C., Wang, J., Huang, X., Zhu, H., Lai, J., & Chen, J. (2024). Droplet digital PCR : An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML. British Journal of Haematology. https://doi.org/10.1111/bjh.19465
Vancouver
Mao S, Lin Y, Qin X, Miao Y, Luo C, Luo C, et al. Droplet digital PCR : An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML. British Journal of Haematology. 2024. doi:10.1111/bjh.19465
BibTeX
@article{Mao2024,
author = {Mao, Shengqiao and Lin, Yuchen and Qin, Xia and Miao, Yan and Luo, Changying and Luo, Chengjuan and Wang, Jianmin and Huang, Xiaohang and Zhu, Hua and Lai, Junchen and Chen, Jing},
title = {Droplet digital PCR : An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19465}
}
EUVIMED